The AstraZeneca COVID-19 vaccine will no longer be the preferred choice for Australians under the age of 50, due to rare but serious blood clotting side effects.
Oxfam has warned that wealthy countries must facilitate cheaper mass-produced COVID-19 vaccines to protect every person in the world to avert an economic catastrophe.
With a tendency to mutate being a hallmark of any pathogen, what can we do to protect ourselves from the threat of more deadly COVID-19 strains?
This winter, for the first time, a new cell-based flu vaccine will be introduced in Australia, in a bid to boost the efficacy rates of national immunisation programs.
Vaccinating surgical patients ahead of the general population has the potential to help avoid thousands of postoperative deaths linked to the virus.
Callington's Netbiokem DSAM+ Hospital Grade Disinfectant is formulated for use in healthcare facilities for broad-scale infection control.
In response to global shortages, Oxair is spreading the word about its off-the-shelf solution — Oxygen Pressure Swing Adsorption (PSA) systems.
When choosing a cleaning or disinfection product for a healthcare facility, one of the factors taken into consideration is the compatibility of the product with the equipment or surface.
Researchers have identified distinct chemical 'signatures' for concussion in the spit of elite male rugby players.
Curtin University research has documented the varied experiences of people involved in receiving and providing maternity care during the pandemic.
Updates to the Australian Asthma Handbook will help health professionals advise patients with asthma during the COVID-19 vaccine rollout.
The report reveals that almost half of abdominal surgery patients in Australia feel they were not given adequate, helpful or accurate information for post-operative recovery.
The update means the resource now includes latest national data on how cancer diagnosis and excess death rates vary by geographical area across Australia.
University of Queensland pain researchers have made a discovery that could let future cancer patients avoid chemotherapy's worst and most debilitating side effects.
Countries that have opted to pause the AstraZeneca vaccine amid unsubstantiated blood clotting fears are actively choosing to end lives, according to Professor Bruce Thompson.